Author: Network Editor

Agenda released for Trend Diabetes National Conference 2024

Dietary approaches to obesity management and diabetic foot care will be among the topics discussed at this year’s Trend Diabetes National Nursing Conference. This year’s event is called ‘Navigating the Path Through Diabetes’ and it will have a strong focus on education. The annual conference is free to all nurses working in diabetes care and healthcare professionals in the UK interested in diabetes care and will feature talks from a range of leading speakers in the field. Debbie Hicks and June James – Co-Chairs of Trend Diabetes and Independent Consultants – Diabetes Nursing – will be chairing the conference. “We are inviting all healthcare professionals to attend the conference as we dive deep into cutting-edge insights, strategies, and innovations in diabetes care,” said Debbie. June added: “We are proud to bring you insights from the best minds in the field. This year’s speaker line-up features presentation sessions from a diverse array of speakers in the field of diabetes, each bringing unique discussions to the forefront.” Sessions during the conference will include: Trend Diabetes update by June James NHS Obesity strategy: how does this work in practice? By Kamlesh Khunti in London and Stephen Lawrence in Birmingham and Newcastle. Kamlesh is a Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and Co-Director of the Leicester Diabetes Centre (LDC) – a world-renowned centre answering the global challenge of type 2 diabetes and long-term conditions through leading research, education and innovation. Stephen is an Associate Clinical Professor at the University of Warwick and a Primary Care Clinical Lead in Chatham. In addition, he has served in a joint role of Primary Care Medical Advisor for Diabetes UK and Clinical Diabetes Lead for the Royal College of General Practitioners. He is also a former Committee Member of the PCDS Dietary approaches to obesity management by Alison Barnes. Alison is a Bank Lead Diabetes Specialist Dietitian at the Newcastle Upon Tyne Hospitals NHS Foundation Trust. She is also the study dietitian for the Diabetes Remission Clinical Trial (DiRECT) in Tyneside The diabetic foot by Fran Game. Fran is a Consultant Diabetologist at University Hospitals of Derby and Burton NHS Foundation Trust The Trans-gender population and CV risk by Kaustubh Nisal. Kaustubh is a Consultant in Diabetes and Endocrinology at Nottingham University Hospitals NHS Trust and the Endocrinology Lead for the Nottingham centre for Transgender Health. The conference will take place on Friday, June 7, at the Thistle Marble Arch in London and then again on Friday, June 14, at the National Conference Centre in Birmingham. The informative event will also be returning to the Hilton in Newcastle on Friday, June 21, after the success of the inaugural Trend Diabetes conference in the North East last year. The events are free to attend, with spaces expected to fill up fast due to limited capacity at all three venues. The organisers have advised those wishing to attend not to register for all three events as the same programme is ran on each day. They have also requested that tickets are not block booked, so just one booking per person. To see the agenda click here. Register your free place here: London – Friday, June 7 Birmingham – Friday, June 14 Newcastle – Friday, June 21

Rowan Hillson Inpatient Diabetes Award 2024 launches with call for entries

One of the biggest awards in inpatient diabetes is once again up for grabs and diabetes teams are being encouraged to enter. The annual award, which is organised by the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) and led by Dr Umesh Dashora, is now open for submissions, and judges want to hear about examples of best practice when it comes to delivering excellent inpatient diabetes care. The judges are looking for innovations that empower people with diabetes, encourage collaboration, hold scalability potential and demonstrate sustainability, value and impact. The ‘prestigious’ Rowan Hillson Inpatient Diabetes Award has been running since 2014 and awards excellence in diabetes care. The deadline for entries is Sunday, June 2. The submissions will be judged against predetermined criteria by an independent panel chaired by Rowan Hillson. For more information and to submit an entry, click here.

Sign up for new AI and diabetic foot ulcer webinar

A forthcoming webinar is to explore how artificial intelligence (AI) can help treat and manage diabetic foot ulcers. Hosted by SpectralMD, the online event will discuss how developing technologies involving AI can improve healing prediction and have a positive impact on patient outcomes. In addition, it will highlight how AI can optimise the clinical management of diabetic foot ulcers (DFU). The webinar – AI in DFU Management: Is the future here already? – will take place virtually on Wednesday, April 17, from 7pm to 8pm. Professor Paul Chadwick, Executive Vice President of SpectralMD, is chairing the online session. He will be joined by Andrew Sharpe, Advanced Podiatrist at Salford Royal NHS Foundation Trust, and Mark Portou, Vascular Consultant at the Royal Free Hospital in London, who are both speaking during the webinar. During the virtual event, delegates will understand the limitations of current DFU assessments and predictive models and hear discussions on how technology is developing to improve predictive accuracy. Those who wish to attend can register for the webinar here.

One week to go until Diabetes Nursing Awards top tips webinar

Entrants to the Diabetes Nursing Awards have one week left to sign up for a free webinar offering advice on how to put together a brilliant award submission. A week today – from 12.30pm on Friday, March 15 – the awards organisers will host a 45-minute webinar called ‘Top tips for an award winning entry’ for anyone interested in entering this year’s awards. The webinar will include advice from a highly successful awards writer followed by a Q&A session. To register for the webinar, click here Diabetes Nursing Awards event organiser Emily Mayhew said: “This year’s Diabetes Nursing Awards will celebrate our nursing heroes and help to elevate diabetes education and care standards. “We know nurses across the country are doing incredible work in the field of diabetes and we want to help them to successfully show off their achievements to our independent panel of expert judges. “To this end we are running a free webinar to give entrants top tips on what makes a compelling award entry. “This will give everyone plenty of time to put together their submissions before the awards deadline at midnight on Friday, March 29.” Nurses can enter submissions in up to two of this year’s eight awards categories, which are: Secondary Care Nurse of the Year Primary Care Nurse of the Year Innovation Award Paediatric Nurse of the Year Diabetes Educator of the Year Service Improvement Project of the Year Research Project of the Year Rising Star Award. The Diabetes Nursing Awards ceremony will be hosted by Dr Sarah Jarvis MBE at Thistle Marble Arch London from 8pm to 11pm on Friday, June 7. To find out more about the awards, visit https://diabetesnursingawards.co.uk The Diabetes Nursing Awards is sponsored and funded by A. Menarini Farmaceutica Internazionale SRL. Menarini has had no input into the arrangement or content of the awards.

Healthcare professionals urged to sign up for new obesity and weight management conference

Hundreds of healthcare professionals have already signed up for a new conference dedicated to obesity and weight management. Registrations for the inaugural Obesity & Weight Management Alliance conference opened during National Obesity Awareness Week in January. The conference – which includes free CPD-accredited education from leading experts – has attracted a huge amount of interest from a wide range of professionals, including consultants, nurses, GPs, dietitians, surgeons, pharmacists, registrars, dentists, psychologists and midwives. Event manager Emily Mayhew said: “Healthcare staff and resources across primary and secondary care are coming under increasing pressure because of the growing number of people living with obesity and weight management challenges. “We want to help healthcare professionals to expand their knowledge and skillset in this area by enabling them to take advantage of free education from the UK’s leading experts at our new conference. “The interest we have had in the event has been incredible and there’s still time for healthcare professionals to register for their free place. “By attending this conference, they will contribute to their own professional development and be able to network with peers and organisations who share their passion for healthcare innovation.” Obesity & Weight Management Alliance 2024 will feature sessions on a wide range of topics, including the causes and consequences of obesity, weight loss and weight loss maintenance, the impact of obesity on pregnancy outcomes, type 2 diabetes and pharmacotherapy. The event will be chaired by Professor Melanie Davies CBE, a Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust. Professor Davies is Co-Director of the Leicester Diabetes Centre and has published more than 900 original articles. The conference, organised by Orange Juice Communications, will take place at National Conference Centre Birmingham on Friday, May 17. Entry to the conference is free but places must be booked in advance at http://tinyurl.com/5n8fbdjs To see the full agenda, visit www.obesityalliance.co.uk/agenda We have received funding by means of sponsorship to the support the delivery of our conference from multiple sponsors. Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Mortality risk of older people with type 2 diabetes reduced by SGLT2 inhibitors, study reveals

Older and frail people living with type 2 diabetes and heart failure are less likely to die if they take sodium-glucose cotransporter-2 (SGLT2) inhibitors, new evidence has shown. Researchers have identified that older people with type 2 diabetes and heart failure who are using SGLT2 inhibitors are less at risk of experiencing cardiac death and being admitted to hospital with heart failure. The study has reported that SGLT2 inhibitors do not prevent older people with the condition from experiencing renal events or macrovascular death. During the trial, the team of scientists looked at the results of 20 studies which compared SGLT2 inhibitors against placebo or other glucose-lowering agents for people aged 65 or older with type 2 diabetes and heart failure. They found that SGLT2 inhibitors were associated with a significant reduction in the risk of all-cause mortality, cardiac death and hospitalisation for heart failure among older and frail people living with type 2 diabetes. Additionally, they discovered that SGLT2 inhibitors did not demonstrate significant effect in reducing in the risk of macrovascular events (acute coronary syndrome or cerebral vascular occlusion), renal progression, composite renal endpoint, acute kidney injury, worsening heart failure, atrial fibrillation or diabetic ketoacidosis. The full study is available here.

Chance to make a difference this World Obesity Day

Today – on World Obesity Day – healthcare professionals are being urged to sign up for a new conference featuring free CPD-accredited education from leading experts. The Obesity & Weight Management Alliance’s inaugural conference will take place on Friday, May 17, at National Conference Centre Birmingham and is free to attend for healthcare professionals. It will feature sessions on a wide range of topics, including the causes and consequences of obesity, weight loss and weight loss maintenance, the impact of obesity on pregnancy outcomes, type 2 diabetes and pharmacotherapy. Event manager Emily Mayhew said: “The theme of this year’s World Obesity Day is ‘Let’s Talk About Obesity And…’ It’s hoped this will inspire people to use the power of conversation to discover how we can address obesity together. “At the Obesity & Weight Management Alliance we’ve taken this idea to heart and have put together a programme featuring world-class speakers who will share their expert insights and knowledge with our audience. This means one of the simplest ways that healthcare professionals can make a difference this World Obesity Day is by registering for our free conference. “Attending the conference will help healthcare professionals expand their knowledge and skillset and stay at the forefront of industry advancements. “They will also have the chance to network with peers who share their desire to help individuals needing support with obesity and weight management challenges.” The conference will be chaired by Professor Melanie Davies CBE, a Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust. Professor Davies is Co-Director of the Leicester Diabetes Centre and has published more than 900 original articles. To see the full agenda, visit www.obesityalliance.co.uk/agenda To secure your free place at the conference, visit http://tinyurl.com/5n8fbdjs

Leicester researcher joins global push to prevent type 1 diabetes

Professor Claire Meek at the University of Leicester is leading one of five global research projects receiving part of £1.5 million funding from JDRF and the Helmsley Charitable Trust to access a unique database which could help prevent type 1 diabetes. Professor Meek is partnering with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. Pioneering in its approach, this study monitors close relatives of people with type 1, beginning when they are still in the womb, to investigate the intricate relationship between environmental factors and an individual’s genes. The primary goal is to unravel the role these factors play in initiating and influencing the development of type 1 diabetes. ENDIA has collected over 200,000 unique biological samples – such as blood, immune cells, breast milk, nasal swabs, stool, and urine samples – along with 16 million medical observations from 1,500 people with a parent or sibling diagnosed with type 1. ENDIA has been supported by JDRF and Helmsley since 2015, and through this partnership, a further £1.5 million is being invested to allow international researchers to collaborate with ENDIA. Professor Meek and the other select researchers will use ENDIA’s extensive resources to investigate new concepts about how type 1 develops. Professor Claire Meek, who is working within the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC) and the Leicester Diabetes Centre (LDC), said: “I am delighted to be one of only five researchers across the world given exclusive access to ENDIA’s unique and unprecedented resources. “I would like to thank JDRF and Helmsley for their longstanding commitment to unravelling the driving forces behind type 1 diabetes. I am honoured to contribute to the research by hunting for any pivotal biological changes that occur during pregnancy that may cause changes in the unborn child’s pancreas that could predict if they will develop type 1 diabetes.” She added: “Along with the other four researchers receiving funding today, my project will bring us closer to being able to prevent type 1 diabetes.” Dr Dorota Pawlak, Chief Scientific Officer at JDRF Australia, said: “ENDIA was the first study of its kind globally. “The richness of the data and uniqueness of biological samples collected puts it at the forefront of research in type 1 diabetes prevention. “This funding announcement will see ENDIA’s impact reach a new international level, by giving the best and brightest type 1 diabetes researchers around the globe access to ENDIA’s precious resources for innovative investigations seeking to uncover new findings.” Professor Meek will hunt for new ways to identify how likely individuals are to develop type 1 by using advanced techniques to identify biological changes during pregnancy that may alter the unborn baby’s pancreas and immunity. By comparing children with different exposures during pregnancy, Professor Meek aims to discover biological markers in newborn babies that could predict type 1. Being able to accurately predict who will develop type 1 will enable us to detect the onset of the condition earlier than ever before. Rachel Connor, Director of Research Partnerships at JDRF UK, said: “JDRF is proud to have supported ENDIA from its inception and it is incredibly exciting to announce this first round of research projects to delve into its fantastic data. “It is more exciting still that one of these five pioneering research projects is taking place here in the UK.” She added: “Through innovative research projects like Professor Claire Meek’s, we hope to reach a point where we can stop type 1 diabetes in its tracks, so that people never experience the burden of managing type 1 diabetes with insulin and we can consign this condition to the history books.” Detecting type 1 earlier than we currently do will help prevent dangerous diagnoses in diabetic ketoacidosis and provide the opportunity for insulin-producing cells to be protected using immunotherapies. Projects like Professor Meek’s offer hope that one day, we will be able to act  early enough in the disease progression to stop the immune attack altogether and prevent the onset of type 1 diabetes. The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester, Loughborough University and the University Hospitals of Northamptonshire NHS Group.

Thank you for your upload